Get the Stockscreener App
1.51
3.82%
-0.06
Pre-market:
1.55
0.04
+2.65%
Ocugen Inc stock is traded at $1.51, with a volume of 4.44M.
It is down -3.82% in the last 24 hours and up +8.63% over the past month.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
See More
Previous Close:
$1.57
Open:
$1.53
24h Volume:
4.44M
Relative Volume:
1.02
Market Cap:
$441.38M
Revenue:
-
Net Income/Loss:
$-63.08M
P/E Ratio:
-5.5926
EPS:
-0.27
Net Cash Flow:
$-72.53M
1W Performance:
-9.58%
1M Performance:
+8.63%
6M Performance:
+119.64%
1Y Performance:
+62.37%
1-Day Range:
$1.47
$1.55
1-Week Range:
$1.47
$1.83
52-Week Range:
$0.515
$1.90
Ocugen Inc Stock (OCGN) Company Profile
Name
Ocugen Inc
Sector
Industry
Phone
484-328-4701
Address
11 GREAT VALLEY PARKWAY, MALVERN, PA
Compare OCGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OCGN
Ocugen Inc
|
1.51 | 490.32M | 0 | -63.08M | -72.53M | -0.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.44 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.90 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
584.74 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
814.17 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.54 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Ocugen Inc Stock (OCGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-15-24 | Initiated | Maxim Group | Buy |
| Mar-01-23 | Upgrade | Chardan Capital Markets | Neutral → Buy |
| Aug-23-22 | Initiated | Mizuho | Buy |
| Jun-15-22 | Resumed | ROTH Capital | Buy |
| Jun-02-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-26-21 | Initiated | Noble Capital Markets | Outperform |
| Jun-11-21 | Downgrade | ROTH Capital | Buy → Neutral |
| May-07-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Feb-09-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Feb-04-21 | Upgrade | H.C. Wainwright | Neutral → Buy |
View All
Ocugen Inc Stock (OCGN) Latest News
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 - GlobeNewswire
Best data tools to analyze Ocugen Inc. stockWeekly Gains Report & Stepwise Entry/Exit Trade Alerts - newser.com
Is Ocugen Inc. still worth holding after the dip2025 Trading Volume Trends & Reliable Price Action Trade Plans - newser.com
Is Ocugen Inc. (2H51) stock a top dividend aristocrat candidateBuy Signal & Safe Capital Investment Plans - newser.com
How Ocugen Inc. (2H51) stock trades pre earningsJuly 2025 Trade Ideas & Community Verified Trade Alerts - newser.com
Ocugen Inc. stock falls Wednesday, underperforms market - MarketWatch
Why millennials buy Ocugen Inc. (2H51) stock2025 Risk Factors & Reliable Momentum Entry Alerts - newser.com
Why Ocugen Inc. (2H51) stock is favored by hedge fundsJuly 2025 Macro Moves & Long-Term Growth Stock Strategies - newser.com
Will Ocugen Inc. (2H51) stock maintain strong growthWeekly Trend Summary & Weekly Watchlist for Consistent Profits - newser.com
Why Ocugen Inc. (2H51) stock trades below fair value2025 Technical Overview & Real-Time Buy Signal Alerts - newser.com
Ocugen Inc. stock falls Tuesday, underperforms market - MarketWatch
Can Ocugen Inc. (2H51) stock sustain double digit ROE2025 Institutional Moves & Weekly Breakout Watchlists - newser.com
Ocugen Inc. Stock Rises Monday, Outperforms Market - 富途牛牛
Can Ocugen Inc. (2H51) stock attract ESG investments2025 Trading Recap & AI Driven Price Predictions - newser.com
Identifying reversal signals in Ocugen Inc.Risk Management & Technical Pattern Based Buy Signals - newser.com
Will Ocugen Inc. stock outperform international peersWeekly Stock Analysis & Capital Efficiency Focused Ideas - newser.com
Will Ocugen Inc. stock maintain dividend yield2025 Market Outlook & Daily Volume Surge Trade Alerts - newser.com
What data driven models say about Ocugen Inc.’s futureJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Will earnings trigger a reversal in Ocugen Inc.2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com
How Ocugen Inc. stock reacts to job market dataMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
Ocugen to Host Q1 2025 Earnings Call and Business Update on May 9 - MSN
How Ocugen Inc. stock compares to industry benchmarksJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - nchmf.gov.vn
How Ocugen Inc. (2H51) stock reacts to new regulations2025 Performance Recap & Technical Pattern Recognition Alerts - nchmf.gov.vn
Will Ocugen Inc. stock benefit from commodity prices2025 Analyst Calls & Risk Controlled Daily Plans - nchmf.gov.vn
What Catalysts Could Shift the Ocugen Story After Recent Analyst Reactions and News? - Yahoo Finance
Earnings Report: How Ocugen Inc. (2H51) stock reacts to new regulations2025 Market WrapUp & Verified High Yield Trade Plans - nchmf.gov.vn
How Ocugen Inc. (2H51) stock moves on employment dataLayoff News & Technical Buy Zone Confirmation - Trung tâm Dự báo KTTV quốc gia
Ocugen Inc Stock (OCGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):